International Biotechnology (IBT) Competitors GBX 546 +10.00 (+1.87%) As of 04/17/2025 11:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock IBT vs. IEM, ICGT, MRCH, SLS, TRG, SDP, GSCT, VOF, PEY, and ESCTShould you be buying International Biotechnology stock or one of its competitors? The main competitors of International Biotechnology include Impax Environmental Markets (IEM), ICG Enterprise Trust (ICGT), The Merchants Trust (MRCH), Standard Life UK Smaller Companies Trust (SLS), The European Smaller Companies Trust (TRG), Schroder Investment Trust - Schroder AsiaPacific Fund (SDP), The Global Smaller Companies Trust (GSCT), VinaCapital Vietnam Opp Fund (VOF), Princess Private Equity (PEY), and The European Smaller Companies Trust (ESCT). These companies are all part of the "asset management" industry. International Biotechnology vs. Impax Environmental Markets ICG Enterprise Trust The Merchants Trust Standard Life UK Smaller Companies Trust The European Smaller Companies Trust Schroder Investment Trust - Schroder AsiaPacific Fund The Global Smaller Companies Trust VinaCapital Vietnam Opp Fund Princess Private Equity The European Smaller Companies Trust Impax Environmental Markets (LON:IEM) and International Biotechnology (LON:IBT) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, earnings, valuation, dividends, profitability and media sentiment. Is IEM or IBT more profitable? International Biotechnology has a net margin of 90.66% compared to Impax Environmental Markets' net margin of -691.26%. International Biotechnology's return on equity of 13.67% beat Impax Environmental Markets' return on equity.Company Net Margins Return on Equity Return on Assets Impax Environmental Markets-691.26% -0.93% -0.44% International Biotechnology 90.66%13.67%3.57% Which has more volatility & risk, IEM or IBT? Impax Environmental Markets has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. Comparatively, International Biotechnology has a beta of 0.21, suggesting that its stock price is 79% less volatile than the S&P 500. Is IEM or IBT a better dividend stock? Impax Environmental Markets pays an annual dividend of GBX 5 per share and has a dividend yield of 1.5%. International Biotechnology pays an annual dividend of GBX 29 per share and has a dividend yield of 5.3%. Impax Environmental Markets pays out -124.4% of its earnings in the form of a dividend. International Biotechnology pays out 27.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Does the MarketBeat Community believe in IEM or IBT? International Biotechnology received 67 more outperform votes than Impax Environmental Markets when rated by MarketBeat users. Likewise, 77.71% of users gave International Biotechnology an outperform vote while only 66.99% of users gave Impax Environmental Markets an outperform vote. CompanyUnderperformOutperformImpax Environmental MarketsOutperform Votes6966.99% Underperform Votes3433.01% International BiotechnologyOutperform Votes13677.71% Underperform Votes3922.29% Do institutionals and insiders have more ownership in IEM or IBT? 41.2% of Impax Environmental Markets shares are owned by institutional investors. Comparatively, 45.2% of International Biotechnology shares are owned by institutional investors. 2.8% of Impax Environmental Markets shares are owned by insiders. Comparatively, 4.2% of International Biotechnology shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has higher valuation & earnings, IEM or IBT? International Biotechnology has higher revenue and earnings than Impax Environmental Markets. Impax Environmental Markets is trading at a lower price-to-earnings ratio than International Biotechnology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImpax Environmental Markets£1.35M568.97-£9.32M-£4.02-82.17International Biotechnology£41.82M4.69£37.91M£104.805.21 Does the media favor IEM or IBT? In the previous week, Impax Environmental Markets had 1 more articles in the media than International Biotechnology. MarketBeat recorded 1 mentions for Impax Environmental Markets and 0 mentions for International Biotechnology. Impax Environmental Markets' average media sentiment score of 0.00 equaled International Biotechnology'saverage media sentiment score. Company Overall Sentiment Impax Environmental Markets Neutral International Biotechnology Neutral SummaryInternational Biotechnology beats Impax Environmental Markets on 12 of the 16 factors compared between the two stocks. Get International Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for IBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBT vs. The Competition Export to ExcelMetricInternational BiotechnologyAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£196.13M£1.10B£3.69B£2.51BDividend Yield4.20%4.36%4.15%4.79%P/E Ratio5.2123.5713.96130.40Price / Sales4.692,228.241,654.46234,760.40Price / Cash155.7460.9950.4028.32Price / Book0.711.103.344.43Net Income£37.91M£261.75M£1.24B£5.89B1 Month Performance-16.00%1.31%0.35%-1.34%1 Year Performance-10.49%1.64%14.75%41.47% International Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBTInternational BiotechnologyN/AGBX 546+1.9%N/A-10.8%£196.13M£41.82M5.21N/AIEMImpax Environmental MarketsN/AGBX 323+3.0%N/A-14.2%£749.84M£1.35M-80.34N/AICGTICG Enterprise TrustN/AGBX 1,154.80+7.9%N/A-3.2%£746.33M£55.63M23.06N/APositive NewsMRCHThe Merchants TrustN/AGBX 493+4.0%N/A-1.5%£733.25M£119.93M6.73N/ANews CoveragePositive NewsSLSStandard Life UK Smaller Companies TrustN/AN/AN/AN/A£715.41M£222.48M3.3710TRGThe European Smaller Companies TrustN/AN/AN/AN/A£701.52M£340.08M2.13N/ASDPSchroder Investment Trust - Schroder AsiaPacific FundN/AGBX 483.60+1.7%N/A-0.8%£683.17M£134.70M5.64N/APositive NewsGSCTThe Global Smaller Companies TrustN/AGBX 141.89+3.9%N/A-8.2%£682.12M£70.77M1.14N/APositive NewsGap UpHigh Trading VolumeVOFVinaCapital Vietnam Opp FundN/AGBX 380-2.8%N/A-16.5%£673.81M£115.59M10.13125News CoverageHigh Trading VolumePEYPrincess Private EquityN/AGBX 9.64+3.4%N/A-7.0%£666.62M£5.19B29.17N/ANegative NewsGap UpESCTThe European Smaller Companies TrustN/AGBX 168.65+3.5%N/A+4.7%£665.22M£96.24M7.95305 Related Companies and Tools Related Companies Impax Environmental Markets Competitors ICG Enterprise Trust Competitors The Merchants Trust Competitors Standard Life UK Smaller Companies Trust Competitors The European Smaller Companies Trust Competitors Schroder Investment Trust - Schroder AsiaPacific Fund Competitors The Global Smaller Companies Trust Competitors VinaCapital Vietnam Opp Fund Competitors Princess Private Equity Competitors The European Smaller Companies Trust Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IBT) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IBT Stock Free IBT Stock Alerts